Thymoxamine on the guinea-pig vas deferens: an effect unrelated to alpha-receptor blockade.
D000109:Acetylcholine / Q000494:pharmacology; D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology*; D000818:Animals; D001241:Aspirin / Q000494:pharmacology; D002800:Cholinesterase Inhibitors; D004305:Dose-Response Relationship, Drug; D004558:Electric Stimulation; D006168:Guinea Pigs; D007001:Hypogastric Plexus / Q000187:drug effects; D066298:In Vitro Techniques; D008297:Male; D013948:Moxisylyte / Q000494:pharmacology*; D009132:Muscles / Q000201:enzymology; D010646:Phentolamine / Q000494:pharmacology; D010656:Phenylephrine / Q000494:pharmacology; D010830:Physostigmine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D012601:Scopolamine / Q000494:pharmacology; D014649:Vas Deferens / Q000187:drug effects*
D000317:Adrenergic alpha-Antagonists; D002800:Cholinesterase Inhibitors; D010656:Phenylephrine; D010830:Physostigmine; D011433:Propranolol; D012601:Scopolamine; D000109:Acetylcholine; D013948:Moxisylyte; D001241:Aspirin; D010646:Phentolamine